Regulatory Features of Mycobacterial Dephosphocoenzyme A Kinase
Author Information
Author(s): Guneet Walia, Avadhesha Surolia
Primary Institution: Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India
Hypothesis
The last enzyme of the Mycobacterium tuberculosis Coenzyme A biosynthetic pathway, dephosphocoenzyme A kinase (CoaE), could be a good anti-tubercular target.
Conclusion
The study reveals that the monomeric form of CoaE is the active form, and its activity is regulated by the interplay between the substrate DCoA and the inhibitor CTP.
Supporting Evidence
- CTP binds tightly to CoaE, inhibiting its activity.
- DCoA promotes the transition of CoaE from an inactive trimeric state to an active monomeric state.
- The study provides insights into the regulatory mechanisms of CoaE, which could be targeted for drug development.
Takeaway
This study looks at how a specific enzyme in bacteria that causes tuberculosis works and how it can be targeted for new treatments.
Methodology
The study used various biochemical assays, including kinetic assays, size exclusion chromatography, and dynamic light scattering to analyze the enzyme's activity and oligomeric status.
Limitations
The study does not explore the full range of potential inhibitors or the effects of other cellular conditions on CoaE activity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website